Home » today » Business » Stagflation and debt fears turn stock markets blood red

Stagflation and debt fears turn stock markets blood red

A heavy sell-off rolled across the stock markets on Friday. Higher-than-expected US inflation has fueled fears of aggressive rate hikes and a recession.

Fears are growing that the US central bank (Fed) will raise interest rates even more aggressively than expected to keep inflation under control. There is speculation that the Fed will raise interest rates by 50 basis points not only in June and July, but also in September. This led to a sharp rise in long-term interest rates in both the US and Europe.

The European Central Bank (ECB) is also planning interest rate hikes. It announced a 0.25 percentage point rate hike for July on Thursday and opened the door for a bigger rate hike in September.

recession

The prospect of much higher central bank policy rates is fueling fears of a recession. This brings the image of stagflation, the combination of high inflation and low or negative economic growth, back to the forefront among investors.

“The more interest rate expectations rise, the more toxic they become to equity markets,” said Thomas Altmann, advisor at asset manager QC Partners. There is a real danger that central banks will bring the economy to a standstill. That danger is increasingly being priced in on the stock markets.’

The ECB’s interest rate decision makes the specter of the debt crisis alive again. Long-term interest rates rose especially in countries with high government debt, such as Italy.

Although the interest rate differentials between the euro countries are still far from the level of the peak of the crisis in 2011, they are rising significantly. The Italian 10-year yield rose to 3.76 percent on Friday. The difference in borrowing costs with the German ten-year interest rate rose to 2.25 percentage points. That led to a shock effect on the Milan stock exchange, which closed 5 percent lower. Italian banks Unicredit and Intesa Sanpaolo lost up to 9 percent.

In Brussels, all sectors lost ground. The biggest losers in the star basket were D’Ieteren (-4.6%), heavyweight KBC (-4.5%) and Ageas (-4.3%). The biotech sector kept the damage limited thanks to a sharp price target increase for Argenx

at the Kepler Cheuvreux stock exchange. Argenx was the only Bel20 stock to finish higher.

Leave a Comment

This site uses Akismet to reduce spam. Learn how your comment data is processed.